Publicaciones (80) Publicaciones de JAVIER ANTONIO MONTERO MORENO

2019

  1. Phenotypic high myopia in X-linked retinitis pigmentosa secondary to a novel mutation in the RPGR gene

    Ophthalmic Genetics, Vol. 40, Núm. 2, pp. 170-176

2016

  1. Component-resolved diagnostics in vernal conjunctivitis

    Current Opinion in Allergy and Clinical Immunology, Vol. 16, Núm. 5, pp. 498-504

  2. Reply

    Retina

2015

  1. Asymmetry in macular choroidal thickness profile between both eyes in a healthy population measured by swept-source optical coherence tomography

    Retina, Vol. 35, Núm. 10, pp. 2067-2073

  2. Component-resolved diagnostics in vernal conjunctivitis

    Annals of Allergy, Asthma and Immunology, Vol. 115, Núm. 5, pp. 446-450

  3. Consensus document on allergic conjunctivitis (DECA)

    Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 2, pp. 94-106

  4. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia six years outcome

    Retina, Vol. 35, Núm. 12, pp. 2450-2456

  5. Morphologic features of the choroidoscleral interface in a healthy population using swept-source optical coherence tomography

    American Journal of Ophthalmology, Vol. 160, Núm. 3, pp. 596-601.e1

2014

  1. Author response: Choroidal thickness and axial length

    Investigative Ophthalmology and Visual Science

  2. Bevacizumab in vitreous haemorrhage secondary to radiation retinopathy

    BMJ Case Reports

  3. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes

    British Journal of Ophthalmology, Vol. 98, Núm. 3, pp. 334-338

  4. Macular choroidal thickness profile in a healthy population measured by swept-source optical coherence tomography

    Investigative Ophthalmology and Visual Science, Vol. 55, Núm. 6, pp. 3532-3542

  5. Management of diabetic macular edema by intravitreal antiangiogenic drugs

    Macular Edema: Risk Factors, Treatment Options and Long-Term Outcomes (Nova Science Publishers, Inc.), pp. 1-30

  6. Management of macular edema secondary to retinal vein occlusion by intravitreal bevacizumab

    Macular Edema: Risk Factors, Treatment Options and Long-Term Outcomes (Nova Science Publishers, Inc.), pp. 31-58

  7. Orbital apex syndrome secondary to herpes zoster virus infection

    BMJ Case Reports

  8. Postoperative cystoid macular edema in diabetic patients: Prophylaxis and management

    Macular Edema: Risk Factors, Treatment Options and Long-Term Outcomes (Nova Science Publishers, Inc.), pp. 59-81

  9. Reply

    Retina

2013

  1. Choroidal thickness study using swept-source optical coherence tomography

    Retina Today, Vol. NOV -DEC, Núm. SUPPL. 2, pp. 1-3

  2. Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-Year outcome

    British Journal of Ophthalmology, Vol. 97, Núm. 11, pp. 1447-1450

  3. Intravitreal bevacizumab in myopic neovascular membranes: 24-month results

    Ophthalmology